Cargando…
Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
Resistin is considered to be a risk factor for several types of cancer, but its functions are controversial and not well studied in lung cancer. The present study is aimed to investigate the expression of resistin in lung adenocarcinoma tissues, in order to evaluate its association with the clinicop...
Autores principales: | Zhao, Cui-Cui, Chen, Jing, Niu, Rui-Fang, Liu, Yan, Zhang, Chuan-Gui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196645/ https://www.ncbi.nlm.nih.gov/pubmed/30272365 http://dx.doi.org/10.3892/or.2018.6736 |
Ejemplares similares
-
[Retracted] Increased resistin suggests poor prognosis and promotes development of lung adenocarcinoma
por: Zhao, Cui-Cui, et al.
Publicado: (2023) -
Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinoma
por: Wei, Dong, et al.
Publicado: (2023) -
FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023) -
Combined High Resistin and EGFR Expression Predicts a Poor Prognosis in Breast Cancer
por: Zeng, Yue, et al.
Publicado: (2020) -
BPTF promotes tumor growth and predicts poor prognosis in lung adenocarcinomas
por: Dai, Meng, et al.
Publicado: (2015)